The Marijuana Enforcement Division (MED) has published the agenda for the second SB23-271 Feasibility Study public stakeholder meeting on Friday, March 8. The agenda includes a continuation of the discussion about the evaluation processes and systems for cannabinoids, as well as the production methods of hemp-derived semi-synthetic cannabinoids, and the potential composition of a standing committee.
MED SB23-271 Public Stakeholder meeting
Friday, March 8, 2024
2 p.m. to 4 p.m.
Options to join:
Join In-Person
1707 Cole Blvd., Ste. 300
Red Rocks Conference Room
Lakewood, CO 80401
Join Zoom Meeting
https://us02web.zoom.us/j/
Meeting ID: 884 9643 8113
Call-in Number: +17193594580
Colorado Senate Bill 23-271 requires the Executive Director of the Department of Revenue to submit a report to the General Assembly analyzing the feasibility of establishing a standing committee to evaluate cannabinoids and cannabis-derived products, for the purpose of determining and making recommendations regarding their safety profiles and potential for intoxication.
Sincerely,
The Marijuana Enforcement Division
